Literature DB >> 28254508

Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18F-MNI-659 and 11C-raclopride with correction for partial volume effect.

Patrik Fazio1, Martin Schain2, Ladislav Mrzljak3, Nahid Amini2, Sangram Nag2, Nabil Al-Tawil4, Cheryl J Fitzer-Attas3, Juliana Bronzova3, Bernhard Landwehrmeyer3, Cristina Sampaio3, Christer Halldin2, Andrea Varrone2.   

Abstract

Phosphodiesterase 10A enzyme (PDE10A) is an important striatal target that has been shown to be affected in patients with neurodegenerative disorders, particularly Huntington´s disease (HD). PDE10A is expressed on striatal neurones in basal ganglia where other known molecular targets are enriched such as dopamine D2/3 receptors (D2/3 R). The aim of this study was to examine the availability of PDE10A enzyme in relation with age and gender and to compare those changes with those related to D2/3 R and volumes in different regions of the basal ganglia. As a secondary objective we examined the relative distribution of D2/3 R and PDE10A enzyme in the striatum and globus pallidus. Forty control subjects (20F/20M; age: 44±11y, age range 27-69) from an ongoing positron emission tomography (PET) study in HD gene expansion carriers were included. Subjects were examined with PET using the high-resolution research tomograph (HRRT) and with 3T magnetic resonance imaging (MRI). The PDE10A radioligand 18F-MNI-659 and D2/3 R radioligand 11C-raclopride were used. The outcome measure was the binding potential (BPND) estimated with the two-tissue compartment model (18F-MNI-659) and the simplified reference tissue model (11C-raclopride) using the cerebellum as reference region. The PET data were corrected for partial volume effects. In the striatum, PDE10A availability showed a significant age-related decline that was larger compared to the age-related decline of D2/3 R availability and to the age-related decline of volumes measured with MRI. In the globus pallidus, a less pronounced decline of PDE10A availability was observed, whereas D2/3 R availability and volumes seemed to be rather stable with aging. The distribution of the PDE10A enzyme was different from the distribution of D2/3 R, with higher availability in the globus pallidus. These results indicate that aging is associated with a considerable physiological reduction of the availability of PDE10A enzyme in the striatum. Moreover as result of the analysis, in the striatum for both the molecular targets, we observed a gender effect with higher BPND the female group.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28254508     DOI: 10.1016/j.neuroimage.2017.02.047

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  7 in total

Review 1.  Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.

Authors:  George S Baillie; Gonzalo S Tejeda; Michy P Kelly
Journal:  Nat Rev Drug Discov       Date:  2019-08-06       Impact factor: 84.694

2.  Imaging phosphodiesterase-10a availability in cocaine use disorder with [11 C]IMA107 and PET.

Authors:  Savannah Tollefson; Joshua Gertler; Michael L Himes; Jennifer Paris; Steve Kendro; Brian Lopresti; N Scott Mason; Rajesh Narendran
Journal:  Synapse       Date:  2018-09-27       Impact factor: 2.562

3.  Test-retest reproducibility of [11C]-L-deprenyl-D2 binding to MAO-B in the human brain.

Authors:  Ryosuke Arakawa; Per Stenkrona; Akihiro Takano; Sangram Nag; Rafael S Maior; Christer Halldin
Journal:  EJNMMI Res       Date:  2017-06-20       Impact factor: 3.138

Review 4.  MRI-Driven PET Image Optimization for Neurological Applications.

Authors:  Yuankai Zhu; Xiaohua Zhu
Journal:  Front Neurosci       Date:  2019-07-31       Impact factor: 4.677

Review 5.  Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016.

Authors:  Susann Schröder; Matthias Scheunemann; Barbara Wenzel; Peter Brust
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

6.  Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [18F]JNJ42259152 PET study in rats.

Authors:  Bart de Laat; Yvonne E Kling; Gwen Schroyen; Maarten Ooms; Jacob M Hooker; Guy Bormans; Koen Van Laere; Jenny Ceccarini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-17       Impact factor: 9.236

Review 7.  Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development.

Authors:  Stuart P McCluskey; Christophe Plisson; Eugenii A Rabiner; Oliver Howes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-21       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.